CHINA BIOMEDICAL GROUP INC
10-Q, 1996-08-15
PHARMACEUTICAL PREPARATIONS
Previous: BLUE FISH CLOTHING INC, NT 10-Q, 1996-08-15
Next: CLASSIC BANCSHARES INC, 8-K, 1996-08-15



                                    Form 10-Q
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

            [x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


                  For the quarterly period ended June 30, 1996

                                       OR

          [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934



                         Commission File Number 0-26886

                             INTERNET HOLDINGS, INC.
                     (formerly China Biomedical Group, Inc.)
             (Exact name of Registrant as specified in its charter)

          State of Utah                                  13-3758042
   (State or other jurisdiction                       (I.R.S. Employer
 of incorporation or organization)                Identification Number)

  c/o The Law Office of Steven A. Sanders, P.C.
      50 Broad Street, Suite 437
       New York, New York                                    10004
(Address of principal executive offices)                   (Zip Code)

Registrant's telephone number, including area code:          (212) 681 8400
                              --------------------
Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by  Section  13 or 15(d) of the  Securities  Act of 1934  during the
preceding 12 months (or for such shorter period that the Registrant was required
to file such reports),  and (2) has been subject to such filing requirements for
the past 90 days.

Yes.....X.....                     No..........



                                       1

<PAGE>




                                     PART I


Item 1.             Financial Statements

Attached.


Item 2.           Management's Discussion and Analysis of Financial
Condition and Results of Operations

Liquidity and Sources of Capital

As of June 30, 1996 the  Registrant  had current  assets of $0.00 as compared to
$89,243 as of March 31, 1996 and $70,558 as of December 31 1995.  The registrant
had total assets of  $3,000,000 as of June 30, 1996. To provide funds for future
development the company intends to do a small private placement once the company
considers market conditions to be favourable.


Results of Operations

It was stated in the 10-Q for the period ended March 31 1996 that the Registrant
had  entered  into a contract  to dispose of its wholly  owned  subsidiary  C.B.
Marketing & Investment Ltd. This was in order to avoid  substantial  liabilities
which would otherwise have been incurred by the Registrant.

This  disposal was approved at a special  meeting of  shareholders  on April 22,
1996.

On June 30, 1996, the Company acquired a license from  Interactive  Media Europe
Ltd to exploit certain of that companies  Internet  related  technologies.  This
license was  acquired by the Company in  exchange  for  3,000,000  shares of its
authorized but unissued shares of common stock.

Currently  the  Company  is  pursuing  a policy of  investing  in  research  and
development to exploit the licences which it has acquired. It does not expect to
realize significant revenues in the immediate future from these activities.


                                       2


<PAGE>



                                     PART II


Item 1.                    Legal Proceedings

Neither  the  Registrant  not  its  subsidiaries   were  subject  to  any  legal
proceedings during the reporting period.


Item 2                     Change in Securities.

Not Applicable


Item 3                     Defaults Upon Senior Securities

Not Applicable


Item 4                     Submission of matters to a Vote of Security Holders

At a special meeting of  shareholders  on April 22, 1996 the Company  approved a
Divestiture  Agreement to dispose of its interest in C.B. Marketing & Investment
Ltd.  A total of 738,859  shares  were  voted in favour of the  divestiture.  No
shares were voted against and 373,210 abstained.


Item 5                     Other Information

On June 30, 1996, the Company acquired a license from  Interactive  Media Europe
Ltd to exploit certain of that companies  Internet  related  technologies.  This
license was  acquired by the Company in  exchange  for  3,000,000  shares of its
authorized but unissued shares of common stock.

The Company's  business direction was changed in connection with the acquisition
of the above license from Interactive Media Europe Ltd. Additionally,  effective
June 30, 1996, the Company's name was changed from China Biomedical  Group, Inc.
to Internet Holdings, Inc.


Item 6                     Exhibits and Reports on Form 8-K

(A)      Exhibits
         1.    Certificate of change of name


                                       3

<PAGE>



(B)    Reports on Form 8-K
         None filed this quarter.





                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereto duly authorized.


         Dated this 14 day of August, 1996

                                    Internet Holdings, Inc.
                                    (the Registrant)


                                    By: /s/ Richard O'Dell Poulden
                                        _____________________________
                                        President


                                       4

<PAGE>



[SEAL] State of Utah
       DEPARTMENT OF COMMERCE
       Division of Corporation & Commercial Code

       150 East 300 South, Second Floor
       P.O. Box 45801
       Salt Lake City, Utah 84145-0801


Greetings:

         The Division of Corporations and Commercial Code has received notice of
the  resignation of your registered  agent. A copy of the resignation  notice is
enclosed for your records.  The  effective  date of the  resignation  is 30 days
after the "date received" stamp indicated on the document.

         Each business  organization is required by law to continuously maintain
a registered agent in Utah. Please appoint a new registered agent and submit the
completed  form below to our  offices  within 30 days.  A  corporation,  limited
partnership,  limited  liability  company  or  dba  is  subject  to  suspension,
revocation or cancellation if it does not file a replacement registered agent.

         You may designate your new registered  agent on this form and return it
to the Division offices. If you have any questions please call (801)530-4849.


Filed in the Division of
Corporations & Commercial Code
of the Utah Dept. of Commerce                          Sincerely,

Date:   7/11/96                                        Korla T. Woods, Director
By:     (Sig. appears here)                            Division of Corporations
        Customer Service Agent                         and Commercial Code


- --------------------------------------------------------------------------------


Name of Business Organization: INTERNET HOLDINGS LTD. fka CHINA BIOMEDICAL
GROUP, INC. File #: 073631

Type of Business Organization (Circle One): [Corporation], Limited Partnership,
Limited Liability Partnership, Limited Liability Company, or DBA.

Old Registered Agent:  ROBERT K. IPSON

Registered Address:  1873 CARRIGAN CIRCLE SALT LAKE CITY, UTAH 84109

New Registered Agent:  ROBERT TEW

New Registered Office Street Address:  2014 EAST RIDGEHILL, BOUNTIFUL, 
UTAH 84010

The above  changes were  authorized  by  resolution  of the  governing  board as
required of our business organization by state law. Under penalties of perjury,
we declare that this  information  is to the best of our  knowledge  and belief,
true, correct and complete.



/s/ Robert Tew                                   /s/ Richard O'Dell Poulden
- ------------------------------                   -------------------------------
Robert Tew                                       Richard O'Dell Poulden
Signature of NEW Registered Agent                Signature of authorized 
                                                 Corporations Officer, General
                                                 Partner or Member or Applicant
                                                 
<PAGE>



State of Utah
Department of Commerce
Division of Corporations and Commercial Code

I Hereby certify that the foregoing has been filed
and approved on the 11 day of July 96
In the office of this Division and hereby issue
this Certificate thereof.

Examiner     (Sig. appears here)  Date: 7/12/96

/s/ Korla T. Woods
- -----------------------------
Korla T. Woods
Division Director


                             ARTICLES OF AMENDMENT

                       TO THE ARTICLES OF INCORPORATION OF

                          CHINA BIOMEDICAL GROUP, INC.

         Pursuant to the  provision of Section  16-10a-1006  of the Utah Revised
Business  Corporation  Act,  China  Biomedical  Group,  Inc.  hereby  adopts the
following amendment to its Articles of Incorporation.


                                   AMENDMENT

         Effective  June  30,  1996,  Article  I of  the  Company's  Article  of
Incorporation is amended to read as follows:

         Article I - Corporate  Name.  The name of the  Corporation  is INTERNET
HOLDINGS, INC. (rp)

                             ADOPTION OF AMENDMENT

         The  above  amendment  to  the  Articles  of   Incorporation  of  China
Biomedical Group,  Inc., was duly adopted by the shareholders of the corporation
on June 15,  1996  pursuant to the  requirements  of the Utah  Revised  Business
Corporation Act, as follows:


Voting              Number of           Undisputed          No. of Votes
Group               Shares              Votes               Represented
Designation         Outstanding         Allowed             by written consent

Common Stock        572,069             572,069             438,750

The shareholders voted pursuant to written consent as follows follows on such
Amendment:

Voting Group                       Votes For                Votes Against
Designation                        Amendment                Amendment

Common Stock                       438,750                  0

         The number of shares cast for the  amendment  by the sole voting  group
was sufficient for approval of the amendment by the voting group.

                                       1

<PAGE>


                        EFFECTIVE DATE OF THIS AMENDMENT

         Pursuant to the  provisions of Section  16-10a-123(2),  this amendment
shall be effective at the beginning of business on June 30, 1996.

         IN WITNESS  WHEREOF,  the undersigned  president and secretary,  having
been  thereunto  duly  authorized,  have  executed  the  foregoing  Articles  of
Amendment for the corporation this 15th day of June, 1996.



                                                 By   /s/ Richard O'Dell Poulden
                                                      -------------------------
                                                      Richard O'Dell Poulden,
                                                      President



Attest:


/s/ Lewis M. Klee
- ----------------------------------
Lewis M. Klee, Assistant Secretary



<PAGE>

                             INTERNET HOLDINGS, INC.
                     (FORMERLY CHINA BIOMEDICAL GROUP, INC.)
                                 BALANCE SHEETS





<TABLE>
<CAPTION>
                                                                                           June 30,          December 31,
                                                                                             1996                1995
                                                                                       -----------------   -----------------
                               ASSETS                                                    (Unaudited)           (Note 1)

<S>                                                                                     <C>                 <C>            
CURRENT ASSETS:
  Cash                                                                                  $              -    $         1,489
  Net assets of discontinued operations                                                                -          8,842,881
                                                                                       -----------------   -----------------

               Total current assets                                                                    -          8,844,370
                                                                                       -----------------   -----------------

INTANGIBLE ASSETS                                                                             3,000,000                    -
                                                                                       -----------------   -----------------

                                                                                          $   3,000,000       $   8,844,370
                                                                                       =================   =================

                          LIABILITIES AND
                        STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
  Loans payable                                                                         $              -     $       70,000
  Accrued expenses                                                                               82,316              75,145
                                                                                       -----------------   -----------------

               Total current liabilities                                                         82,316             145,145
                                                                                       -----------------   -----------------

STOCKHOLDERS' EQUITY:
  Common stock, $.001 par value, 50,000,000 shares
    authorized, 4,688,069 and 1,112,069 shares issued and
    outstanding, respectively                                                                     4,688               1,112
  Additional paid-in capital                                                                  7,906,386          13,292,503
  Accumulated deficit                                                                        (4,993,390)         (4,594,390)
                                                                                       -----------------   -----------------

               Total stockholders' equity                                                     2,917,684           8,699,225
                                                                                       -----------------   -----------------

                                                                                          $ 3,000,000         $   8,844,370
                                                                                       =================   =================
</TABLE>



                       See notes to financial statements.
                                       F-1
<PAGE>


                             INTERNET HOLDINGS, INC.
                     (FORMERLY CHINA BIOMEDICAL GROUP, INC.)
                            STATEMENTS OF OPERATIONS
                                   (UNAUDITED)



<TABLE>
<CAPTION>

                                                                    Three months ended June 30,         Six months ended June 30,
                                                                        1996          1995             1996               1995
                                                                  -------------   ------------   ----------------   ----------------

<S>                                                                <C>            <C>            <C>                <C>           
NET SALES AND REVENUES                                             $      --      $      --      $           --     $           --

SELLING, OPERATING AND ADMINISTRATIVE
  EXPENSES                                                             153,710           --               153,710               --
                                                                   -----------    -----------    ----------------   ----------------

          Loss from continuing operations                             (153,710)          --              (153,710)              --

LOSS FROM OPERATIONS OF DISCONTINUED
  SUBSIDIARY                                                              --         (460,613)           (245,290)       (1,056,938)
                                                                   -----------    -----------    ----------------   ----------------

          Net loss                                                 $  (153,710)   $  (460,613)   $       (399,000)  $    (1,056,938)
                                                                   ===========    ===========    ================   ================

WEIGHTED AVERAGE NUMBER OF COMMON
  SHARES OUTSTANDING                                                   825,034        881,000             968,553           618,394
                                                                   ===========    ===========    ================   ================

          Loss from continuing operations per share                 $   (0.19     $       --          $     (0.16)       $        --
                                                                   ===========    ===========    ================   ================

          Net loss per share                                       $     (0.19)   $     (0.52)   $          (0.41)  $         (1.71)
                                                                   ===========    ===========    ================   ================

</TABLE>
















                       See notes to financial statements.
                                       F-2

<PAGE>



                             INTERNET HOLDINGS, INC.
                     (FORMERLY CHINA BIOMEDICAL GROUP, INC.)
                            STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)





<TABLE>
<CAPTION>
                                                                                  Six Months Ended June 30,
                                                                           -----------------------------------------
                                                                                  1996                  1995
                                                                           -------------------   -------------------

<S>                                                                          <C>                   <C>              
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss                                                                     $       (399,000)     $     (1,056,938)
Adjustments to reconcile net loss
  to net cash used by operating
  activities:
  Decrease in accounts receivable                                                        -                    6,910
  Decrease in accrued expenses                                                          7,171                   797
  Decrease in bank overdraft                                                             -                   (7,707)
                                                                           -------------------   -------------------

     Net cash used by operating activities                                           (391,829)           (1,056,938)
                                                                           -------------------   -------------------

CASH FLOWS FROM INVESTING ACTIVITIES:
(Increase) decrease in net assets of discontinued operations                        8,842,881            (8,556,247)
Increase in intangible assets                                                      (3,000,000)                 -
                                                                           -------------------   -------------------

     Net cash provided (used) by investing activities                               5,842,881            (8,556,247)
                                                                           -------------------   -------------------

CASH FLOWS FROM FINANCING ACTIVITIES:
Increase in common stock and additional paid-in capital                             3,533,050             9,613,185
Decrease in common stock and additional paid-in capital                            (8,915,591)                  -
Decrease in loans payable                                                             (70,000)                  -
                                                                           -------------------   -------------------

     Net cash provided (used) by financing activities                              (5,452,541)            9,613,185
                                                                           -------------------   -------------------

NET INCREASE (DECREASE) IN CASH                                                        (1,489)                  -

CASH, BEGINNING OF PERIOD                                                               1,489                   -
                                                                           -------------------   -------------------

CASH, END OF PERIOD                                                         $            -        $             -
                                                                           ===================   ===================

</TABLE>













                       See notes to financial statements.
                                       F-3



<PAGE>



                             INTERNET HOLDINGS, INC.
                     (FORMERLY CHINA BIOMEDICAL GROUP, INC.)
                          NOTES TO FINANCIAL STATEMENTS
                                   (UNAUDITED)


(1)      Basis of presentation

         The accompanying  unaudited financial  statements have been prepared in
         accordance with generally  accepted  accounting  principles for interim
         financial  information  and  with  the  instructions  to Form  10-Q and
         Article 10 of Regulation S-X.  Accordingly,  they do not include all of
         the information and footnotes required by generally accepted accounting
         principles  for complete  financial  statements.  The balance  sheet at
         December  31,  1995  has  been  derived  from  the  audited   financial
         statements at that date. In the opinion of management,  all adjustments
         (consisting of normal  recurring  adjustments  and certain  adjustments
         discussed in Note (2))  considered  necessary  for a fair  presentation
         have been included. Operating results for the three-month and six-month
         periods  ended  June 30,  1996 are not  necessarily  indicative  of the
         results that may be expected for the year ended  December 31, 1996. For
         further information, refer to the consolidated financial statements and
         footnotes thereto for the year ended December 31, 1995.

(2)      Discontinued operations

         On April 22, 1996, China Biomedical Group, Inc. (the "Company") entered
         into an agreement to sell its  wholly-owned  operating  subsidiary,  CB
         Marketing and Investment Ltd. (the  "Subsidiary")  to its former owners
         on the  basis  of one  share  of the  Subsidiary  for one  share of the
         Company.  Accordingly,  the assets and liabilities of the Subsidiary as
         of December 31, 1995 have been  restated as net assets of  discontinued
         operations,  and the  operating  results for the  Subsidiary  have been
         reflected as loss from  operations of  discontinued  subsidiary for all
         periods presented.

(3)      Intangible assets

         Effective  June 30, 1996,  the Company issued 3 million shares of $.001
         par value common stock in connection  with the  acquisition  of certain
         media related licenses which have been valued at $3,000,000.

(4)      Change of name

         Effective  June 30,  1996,  the  Company  changed  its name to Internet
Holdings, Inc.


                                       F-4

<PAGE>


<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 APR-01-1996
<PERIOD-END>                                   JUN-30-1996
<CASH>                                         0
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0
<PP&E>                                         0
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 3,000,000
<CURRENT-LIABILITIES>                          82,316
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       4,688
<OTHER-SE>                                     2,912,996
<TOTAL-LIABILITY-AND-EQUITY>                   3,000,000
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               153,710
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                (153,710)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (153,710)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (153,710)
<EPS-PRIMARY>                                  (.19)
<EPS-DILUTED>                                  0
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission